[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355329-105":59,"doc-detail-355329-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","deciphering-the-erna-landscape-and-revealing-target-aberrant-pathways-in-prostate-cancer","Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer","","Enhancer RNAs (eRNAs) act as regulators of gene expression and may reshape prostate cancer therapeutics, yet their global landscape and clinical relevance remain insufficiently defined. This study integrates prostate cancer multi-omics with functional genomics to map genome-wide eRNA transcription, build eRNA-centered regulatory networks, and connect eRNA-regulated genes to patient outcomes. Functional validation using siRNA knockdown demonstrates that representative eRNAs suppress proliferation, migration, and invasion.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deciphering-the-erna-landscape-and-revealing-target-aberrant-pathways-in-prostate-cancer/355329/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deciphering-the-erna-landscape-and-revealing-target-aberrant-pathways-in-prostate-cancer/355329.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on eRNAs in prostate cancer?","Question",{"text":112,"@type":113},"The study aims to identify eRNA-regulated genes in prostate cancer by characterizing the global eRNA landscape, constructing eRNA-centered regulatory networks, and linking those networks to clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were eRNAs and their regulatory relationships determined?",{"text":117,"@type":113},"The researchers integrated prostate cancer multi-omics and functional genomics datasets to characterize genome-wide eRNA transcription, build regulatory networks, and connect eRNA-regulated genes with clinical survival associations.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the functional importance of representative eRNAs?",{"text":121,"@type":113},"siRNA-mediated knockdown of representative eRNAs in prostate cancer cell lines reduced proliferation, migration, and invasion, alongside decreased expression of target genes NUP93 and BICD1.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355329,1790242004,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Yu etal. BMC Cancer (2026) 26:354 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15675-2](https://doi.org/10.1186/s12885-026-15675-2)  \nRESEARCH Open Access  \nDeciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer  \nChengling Yu1, Yong Wen2, Yanguo Li3, Baiyang Song4,5, Yiwei Hu4, Zixing Meng4, Zejun Yan1,5,6,7*, Wei Du2* and Hao Rong4*  \nAbstract  \nBackground Enhancer RNAs (eRNAs) have emerged as important regulators of gene expression and may reshape the therapeutic landscape of prostate cancer. However, their global landscape and clinical relevance in prostate cancer remain unclear.  \nMethods We systematically integrated prostate cancer multi-omics and functional genomics datasets to characterize genome-wide eRNA transcription, construct eRNA-centered regulatory networks, and link eRNA-regulated genes to clinical outcomes. Representative eRNAs and their predicted target genes were further subjected to siRNA-mediated knockdown and functional validation in prostate cancer cell lines.  \nResults We identified 13,595 eRNAs and 1,573 eRNA-regulated genes, including 266 transcription factors and 85 RNA-binding proteins. eRNA-regulated genes showed higher expression levels, lower variability, and enrichment in prostate cancer–related pathways. A five-gene eRNA-associated signature stratified patients into high-and low-risk groups with AUCs of 0 . 85, 0 . 77, and 0.89 for 1-, 3-, and 5-year survival and remained an independent prognostic factor. The two risk groups exhibited distinct genetic, transcriptomic, and epigenetic features. Functional validation further demonstrated that knockdown of representative eRNAs suppressed prostate cancer cell proliferation, migration, and invasion, accompanied by reduced expression of the target genes NUP93 and BICD1 .  \nConclusion These findings indicate that eRNAs may contribute to prostate cancer biology and could serve as useful markers for prognosis and pathway characterization.  \nKeywords Non-coding RNA, Enhancer RNA, Regulated network, Prostate cancer  \n*Correspondence:  \nZejun Yan [fyyyanzejun@nbu.edu.cn](fyyyanzejun@nbu.edu.cn)[ ](fyyyanzejun@nbu.edu.cn)Wei Du [dwzjyy12@163.com](dwzjyy12@163.com)[ ](dwzjyy12@163.com)Hao Rong [rhsitnbu@gmail.com](rhsitnbu@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nYu et al. BMC Cancer (2026) 26:354  \nBackground  \nProstate cancer is one of the most prevalent malignancies worldwide, with an estimated 1.41 million new cases and 375,000 deaths annually [1]. Despite substantial advancesin diagnosis and treatment, prostate cancer remains a major clinical challenge, particularly due to its molecular heterogeneity and variable clinical outcomes [2]. Identifying novel regulatory mechanisms and molecular markers is therefore essential for improving prognostic strat","cbCaiiZWlsX2Ktej","https://ap.wps.com/l/cbCaiiZWlsX2Ktej","pdf",15995369,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n## Clinical challenge of prostate cancer\n## Role of enhancer RNAs in gene regulation\n## eRNA dysregulation in prostate cancer\n## Need for systematic characterization\n# Research challenges and study aim","[{\"question\":\"What is the main goal of this study on eRNAs in prostate cancer?\",\"answer\":\"The study aims to identify eRNA-regulated genes in prostate cancer by characterizing the global eRNA landscape, constructing eRNA-centered regulatory networks, and linking those networks to clinical outcomes.\"},{\"question\":\"How were eRNAs and their regulatory relationships determined?\",\"answer\":\"The researchers integrated prostate cancer multi-omics and functional genomics datasets to characterize genome-wide eRNA transcription, build regulatory networks, and connect eRNA-regulated genes with clinical survival associations.\"},{\"question\":\"What evidence supports the functional importance of representative eRNAs?\",\"answer\":\"siRNA-mediated knockdown of representative eRNAs in prostate cancer cell lines reduced proliferation, migration, and invasion, alongside decreased expression of target genes NUP93 and BICD1.\"}]","Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer | PDF",1790117812,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/596e9e1370a0ae5f9e1f209ff22c3aa0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c005f0e2457d72bd9e8057da31aab35a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff52141470a09e508b412d10c963c60c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6a5e91207247ef5459a24f3c1b954b1.webp",980,1306]